Dose Ranging Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Diabetic Macular Edema
Clinical trial NCT00656643 · COMPLETED
Trial details
- NCT number
- NCT00656643
- Sponsor
- Santen Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2009-11-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.